Shinpoong Pharmaceutical Co.,Ltd (019175.KS) KSC

Currency In KRW

AD

Valuation

Market Cap774.8B
Enterprise Value783.22B
P/E Ratio-850.26
PEG Ratio6.28
Price/Sales Ratio1.76
Price/Book Ratio1.57
Enterprise/Revenue1.78
Enterprise/EBITDA29.18

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue234.68B
Revenue/Share4,451.9
Gross Profit102.37B
EBITDA25.65B
Net Income8.83B
Diluted EPS172

Balance Sheet

Total Cash72.3B
Total Cash/Share1,346.32
Total Debt53.28B
Total Debt/Equity0.19
Current Ratio2.86
Book Value Per Share5,177.62

Price History

52-Week Change-46.56
52-Week High28,500
52-Week Low7,570
Moving Average 50 Days12,688.2
Moving Average 200 Days18,380.25

Statistics

Average Volume2,850
Shares Outstanding26.5M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor130001:125000
Last Split DateDecember 29, 2014
AD